Menu
Back to User profile » Dr Yongxu Jia
Papers published by Dr Yongxu Jia:
A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy
Shi L, Wang Z, Wang L, Jia Y, Li J, Qin Y
Cancer Management and Research 2022, 14:287-301
Published Date: 25 January 2022
Clinical efficacy and survival analysis of apatinib combined with docetaxel in advanced esophageal cancer
Li J, Jia YX, Gao YP, Chang ZW, Han HQ, Yan J, Qin YR
OncoTargets and Therapy 2019, 12:2577-2583
Published Date: 8 April 2019
Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients
Jia YX, Gao YP, Li J, Chang ZW, Yan J, Qin YR
OncoTargets and Therapy 2019, 12:1129-1135
Published Date: 11 February 2019
Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling [Retraction]
Yan J, Du P, Jia Y, Chang Z, Gan S, Xu X, Wang Y, Qin Y, Kan Q
OncoTargets and Therapy 2018, 11:5045-5046
Published Date: 21 August 2018
Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling
Yan J, Du P, Jia Y, Chang Z, Gan S, Xu X, Wang Y, Qin Y, Kan Q
OncoTargets and Therapy 2018, 11:3323-3333
Published Date: 6 June 2018
Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients
Tang H, Wu Y, Qin Y, Wang H, Jia Y, Yang S, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:2553-2560
Published Date: 15 May 2017
The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study
Jia YX, Li TF, Zhang DD, Fan ZM, Fan HJ, Yan J, Chen LJ, Tang H, Qin YR, Li XY
OncoTargets and Therapy 2016, 9:5919-5929
Published Date: 27 September 2016